Bronson Point Management’s Pfizer PFE Stock Holding History

Bronson Point Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-42,500	Closed	-$1.54M	–	52
2021 Q1	$1.54M	Hold	42,500	–	–	0.65%	33
2020 Q4	$1.56M	Sell	42,500 -4,930	-10%	-$181K	0.62%	38
2020 Q3	$1.65M	Buy	+47,430	New	+$1.66M	1.32%	25

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bronson Point Management's PFE Position: Q2 2021 in Review

Bronson Point Management sold out of Pfizer (PFE) in Q2 2021, closing a stake of 42,500 shares — an estimated $1.54M sold.

Bronson Point Management first reported a position in PFE in Q3 2020 and held it in 3 quarters. The position peaked at $1.65M in Q3 2020. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Bronson Point Management reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Bronson Point Management sold 42,500 Pfizer shares in Q2 2021, an estimated $1.54M.
Bronson Point Management first reported a position in Pfizer in Q3 2020 and held it in 3 quarters.
Bronson Point Management's Pfizer position peaked at $1.65M in Q3 2020.
2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Bronson Point Management's 13F filing for Q2 2021, filed 16 Aug 2021.